These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7607504)

  • 61. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors.
    Lu D; Kiriyama Y; Lee KY; Giguère V
    Cancer Res; 2001 Sep; 61(18):6755-61. PubMed ID: 11559547
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Expression of pS2 protein in breast cancer and its relationship with estrogen and progesterone receptors].
    Díez Gibert O; Machuca I; Sebastián MA; Rosel P; Navarro MA
    Med Clin (Barc); 1996 Jun; 107(3):90-2. PubMed ID: 8754494
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Polymerase chain reaction-aided genomic sequencing of an X chromosome-linked CpG island: methylation patterns suggest clonal inheritance, CpG site autonomy, and an explanation of activity state stability.
    Pfeifer GP; Steigerwald SD; Hansen RS; Gartler SM; Riggs AD
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8252-6. PubMed ID: 2236038
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Methylation of CpG dinucleotides in the lacI gene of the Big Blue transgenic mouse.
    You YH; Halangoda A; Buettner V; Hill K; Sommer S; Pfeifer G
    Mutat Res; 1998 Dec; 420(1-3):55-65. PubMed ID: 9838042
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells.
    Rice JC; Massey-Brown KS; Futscher BW
    Oncogene; 1998 Oct; 17(14):1807-12. PubMed ID: 9778046
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer.
    Fujii H; Biel MA; Zhou W; Weitzman SA; Baylin SB; Gabrielson E
    Oncogene; 1998 Apr; 16(16):2159-64. PubMed ID: 9572497
    [TBL] [Abstract][Full Text] [Related]  

  • 67. PS2 expression in BRCA1-associated breast cancers.
    Charafe-Jauffre E; Eisinger F; Mathoulin-Portier MP; Sobol H; Jacquemier J
    Anticancer Res; 2001; 21(4B):2877-81. PubMed ID: 11712780
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
    Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
    Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
    Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
    Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hormone-regulated genes (pS2, PIP, FAS) in breast cancer and nontumoral mammary tissue.
    Hähnel E; Harvey J; Robbins P; Sterrett G; Hähnel R
    Pathobiology; 1994; 62(2):82-9. PubMed ID: 7945916
    [TBL] [Abstract][Full Text] [Related]  

  • 71. pS2 transfection of murine adenocarcinoma cell line 410.4 enhances dispersed growth pattern in a 3-D collagen gel.
    Williams R; Stamp GW; Gilbert C; Pignatelli M; Lalani EN
    J Cell Sci; 1996 Jan; 109 ( Pt 1)():63-71. PubMed ID: 8834791
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Growth hormone gene structure in human pituitary somatotrophinomas: promoter region sequence and methylation studies.
    Hüttner A; Adams EF; Buchfelder M; Fahlbusch R
    J Mol Endocrinol; 1994 Apr; 12(2):167-72. PubMed ID: 8060481
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of the pS2 gene in normal breast tissue.
    Hähnel E; Robbins P; Hähnel R
    Breast Cancer Res Treat; 1993 Dec; 28(3):295-7. PubMed ID: 8018958
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissues.
    Dietrich D; Lesche R; Tetzner R; Krispin M; Dietrich J; Haedicke W; Schuster M; Kristiansen G
    J Histochem Cytochem; 2009 May; 57(5):477-89. PubMed ID: 19153192
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genomic sequencing indicates a correlation between DNA hypomethylation in the 5' region of the pS2 gene and its expression in human breast cancer cell lines.
    Martin V; Ribieras S; Song-Wang X; Rio MC; Dante R
    Gene; 1995 May; 157(1-2):261-4. PubMed ID: 7607504
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Involvement of DNA methylation in the control of the expression of an estrogen-induced breast-cancer-associated protein (pS2) in human breast cancers.
    Martin V; Ribieras S; Song-Wang XG; Lasne Y; Frappart L; Rio MC; Dante R
    J Cell Biochem; 1997 Apr; 65(1):95-106. PubMed ID: 9138084
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Structure of the human oestrogen-responsive gene pS2.
    Jeltsch JM; Roberts M; Schatz C; Garnier JM; Brown AM; Chambon P
    Nucleic Acids Res; 1987 Feb; 15(4):1401-14. PubMed ID: 3822834
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines.
    Giamarchi C; Solanas M; Chailleux C; Augereau P; Vignon F; Rochefort H; Richard-Foy H
    Oncogene; 1999 Jan; 18(2):533-41. PubMed ID: 9927210
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The pS2 gene, mRNA, and protein: a potential marker for human breast cancer.
    Rio MC; Chambon P
    Cancer Cells; 1990; 2(8-9):269-74. PubMed ID: 2223388
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression of the oestrogen responsive protein pS2 in human breast cancer.
    Balleine RL; Clarke CL
    Histol Histopathol; 1999 Apr; 14(2):571-8. PubMed ID: 10212819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.